Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial

Augustine N. Odili, Tom Richart, Lutgarde Thijs, Samuel Kingue, Hilaire J. Boombhi, Daniel Lemogoum, Joseph Kaptue, Marius K. Kamdem, Jean-Bruno Mipinda, Babatunde A. Omotoso, Philip M. Kolo, Ademola Aderibigbe, Ifeoma I. Ulasi, Benedict C. Anisiuba, Chinwuba K. Ijoma, Serigne A. Ba, Mouhamadou B. Ndiaye, Jan A. Staessen, Jean-Rene M'buyamba-Kabangu

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)256-266
JournalBlood Pressure
Volume20
Issue number5
DOIs
Publication statusPublished - Oct 2011

Keywords

  • Antihypertensive therapy
  • health policy and outcome research
  • randomized clinical trial
  • special populations

Cite this

Odili, A. N., Richart, T., Thijs, L., Kingue, S., Boombhi, H. J., Lemogoum, D., Kaptue, J., Kamdem, M. K., Mipinda, J-B., Omotoso, B. A., Kolo, P. M., Aderibigbe, A., Ulasi, I. I., Anisiuba, B. C., Ijoma, C. K., Ba, S. A., Ndiaye, M. B., Staessen, J. A., & M'buyamba-Kabangu, J-R. (2011). Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial. Blood Pressure, 20(5), 256-266. https://doi.org/10.3109/08037051.2011.572614